The global market for Biomarker Clinical Phase Outsourcing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Biomarker Clinical Phase Outsourcing Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Biomarker Clinical Phase Outsourcing Services include ICON plc, Fujirebio lnc, Charles River Laboratories International,Inc., Laboratory Corporation of America Holdings, Parexel lnternational Corporation, Proteome Sciences plc, Eurofins Scientific, Wuxi AppTec Co., Ltd., NorthEast BioAnalytical Laboratories LLC., Celerion, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biomarker Clinical Phase Outsourcing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Clinical Phase Outsourcing Services.

The Biomarker Clinical Phase Outsourcing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker Clinical Phase Outsourcing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biomarker Clinical Phase Outsourcing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biomarker Clinical Phase Outsourcing Services Market Report

Report Metric	Details
Report Name	Biomarker Clinical Phase Outsourcing Services Market
Segment by Type	Predictive Biomarker Prognostic Biomarker Safety Biomarker Surrogate Endpoints
Segment by Application	Pharmaceutical Companies Biotechnology Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ICON plc, Fujirebio lnc, Charles River Laboratories International,Inc., Laboratory Corporation of America Holdings, Parexel lnternational Corporation, Proteome Sciences plc, Eurofins Scientific, Wuxi AppTec Co., Ltd., NorthEast BioAnalytical Laboratories LLC., Celerion, Inc., GenScript ProBio Co.,Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Clinical Phase Outsourcing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biomarker Clinical Phase Outsourcing Services Market report?

Ans: The main players in the Biomarker Clinical Phase Outsourcing Services Market are ICON plc, Fujirebio lnc, Charles River Laboratories International,Inc., Laboratory Corporation of America Holdings, Parexel lnternational Corporation, Proteome Sciences plc, Eurofins Scientific, Wuxi AppTec Co., Ltd., NorthEast BioAnalytical Laboratories LLC., Celerion, Inc., GenScript ProBio Co.,Ltd.

What are the Application segmentation covered in the Biomarker Clinical Phase Outsourcing Services Market report?

Ans: The Applications covered in the Biomarker Clinical Phase Outsourcing Services Market report are Pharmaceutical Companies, Biotechnology Companies, Others

What are the Type segmentation covered in the Biomarker Clinical Phase Outsourcing Services Market report?

Ans: The Types covered in the Biomarker Clinical Phase Outsourcing Services Market report are Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Surrogate Endpoints

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Predictive Biomarker

1.2.3 Prognostic Biomarker

1.2.4 Safety Biomarker

1.2.5 Surrogate Endpoints

1.3 Market by Application

1.3.1 Global Biomarker Clinical Phase Outsourcing Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Biotechnology Companies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biomarker Clinical Phase Outsourcing Services Market Perspective (2020-2031)

2.2 Global Biomarker Clinical Phase Outsourcing Services Growth Trends by Region

2.2.1 Global Biomarker Clinical Phase Outsourcing Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biomarker Clinical Phase Outsourcing Services Historic Market Size by Region (2020-2025)

2.2.3 Biomarker Clinical Phase Outsourcing Services Forecasted Market Size by Region (2026-2031)

2.3 Biomarker Clinical Phase Outsourcing Services Market Dynamics

2.3.1 Biomarker Clinical Phase Outsourcing Services Industry Trends

2.3.2 Biomarker Clinical Phase Outsourcing Services Market Drivers

2.3.3 Biomarker Clinical Phase Outsourcing Services Market Challenges

2.3.4 Biomarker Clinical Phase Outsourcing Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biomarker Clinical Phase Outsourcing Services Players by Revenue

3.1.1 Global Top Biomarker Clinical Phase Outsourcing Services Players by Revenue (2020-2025)

3.1.2 Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Players (2020-2025)

3.2 Global Biomarker Clinical Phase Outsourcing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biomarker Clinical Phase Outsourcing Services Revenue

3.4 Global Biomarker Clinical Phase Outsourcing Services Market Concentration Ratio

3.4.1 Global Biomarker Clinical Phase Outsourcing Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biomarker Clinical Phase Outsourcing Services Revenue in 2024

3.5 Global Key Players of Biomarker Clinical Phase Outsourcing Services Head office and Area Served

3.6 Global Key Players of Biomarker Clinical Phase Outsourcing Services, Product and Application

3.7 Global Key Players of Biomarker Clinical Phase Outsourcing Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker Clinical Phase Outsourcing Services Breakdown Data by Type

4.1 Global Biomarker Clinical Phase Outsourcing Services Historic Market Size by Type (2020-2025)

4.2 Global Biomarker Clinical Phase Outsourcing Services Forecasted Market Size by Type (2026-2031)

5 Biomarker Clinical Phase Outsourcing Services Breakdown Data by Application

5.1 Global Biomarker Clinical Phase Outsourcing Services Historic Market Size by Application (2020-2025)

5.2 Global Biomarker Clinical Phase Outsourcing Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biomarker Clinical Phase Outsourcing Services Market Size (2020-2031)

6.2 North America Biomarker Clinical Phase Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025)

6.4 North America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biomarker Clinical Phase Outsourcing Services Market Size (2020-2031)

7.2 Europe Biomarker Clinical Phase Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025)

7.4 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size (2020-2031)

8.2 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biomarker Clinical Phase Outsourcing Services Market Size (2020-2031)

9.2 Latin America Biomarker Clinical Phase Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025)

9.4 Latin America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size (2020-2031)

10.2 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ICON plc

11.1.1 ICON plc Company Details

11.1.2 ICON plc Business Overview

11.1.3 ICON plc Biomarker Clinical Phase Outsourcing Services Introduction

11.1.4 ICON plc Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.1.5 ICON plc Recent Development

11.2 Fujirebio lnc

11.2.1 Fujirebio lnc Company Details

11.2.2 Fujirebio lnc Business Overview

11.2.3 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Introduction

11.2.4 Fujirebio lnc Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.2.5 Fujirebio lnc Recent Development

11.3 Charles River Laboratories International,Inc.

11.3.1 Charles River Laboratories International,Inc. Company Details

11.3.2 Charles River Laboratories International,Inc. Business Overview

11.3.3 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Introduction

11.3.4 Charles River Laboratories International,Inc. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.3.5 Charles River Laboratories International,Inc. Recent Development

11.4 Laboratory Corporation of America Holdings

11.4.1 Laboratory Corporation of America Holdings Company Details

11.4.2 Laboratory Corporation of America Holdings Business Overview

11.4.3 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Introduction

11.4.4 Laboratory Corporation of America Holdings Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.4.5 Laboratory Corporation of America Holdings Recent Development

11.5 Parexel lnternational Corporation

11.5.1 Parexel lnternational Corporation Company Details

11.5.2 Parexel lnternational Corporation Business Overview

11.5.3 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Introduction

11.5.4 Parexel lnternational Corporation Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.5.5 Parexel lnternational Corporation Recent Development

11.6 Proteome Sciences plc

11.6.1 Proteome Sciences plc Company Details

11.6.2 Proteome Sciences plc Business Overview

11.6.3 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Introduction

11.6.4 Proteome Sciences plc Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.6.5 Proteome Sciences plc Recent Development

11.7 Eurofins Scientific

11.7.1 Eurofins Scientific Company Details

11.7.2 Eurofins Scientific Business Overview

11.7.3 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Introduction

11.7.4 Eurofins Scientific Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.7.5 Eurofins Scientific Recent Development

11.8 Wuxi AppTec Co., Ltd.

11.8.1 Wuxi AppTec Co., Ltd. Company Details

11.8.2 Wuxi AppTec Co., Ltd. Business Overview

11.8.3 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Introduction

11.8.4 Wuxi AppTec Co., Ltd. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.8.5 Wuxi AppTec Co., Ltd. Recent Development

11.9 NorthEast BioAnalytical Laboratories LLC.

11.9.1 NorthEast BioAnalytical Laboratories LLC. Company Details

11.9.2 NorthEast BioAnalytical Laboratories LLC. Business Overview

11.9.3 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Introduction

11.9.4 NorthEast BioAnalytical Laboratories LLC. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.9.5 NorthEast BioAnalytical Laboratories LLC. Recent Development

11.10 Celerion, Inc.

11.10.1 Celerion, Inc. Company Details

11.10.2 Celerion, Inc. Business Overview

11.10.3 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Introduction

11.10.4 Celerion, Inc. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.10.5 Celerion, Inc. Recent Development

11.11 GenScript ProBio Co.,Ltd.

11.11.1 GenScript ProBio Co.,Ltd. Company Details

11.11.2 GenScript ProBio Co.,Ltd. Business Overview

11.11.3 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Introduction

11.11.4 GenScript ProBio Co.,Ltd. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

11.11.5 GenScript ProBio Co.,Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ICON

Charles River Laboratories International, Inc.

Parexel lnternational Corporation

Proteome Sciences plc

GenScript ProBio Co.,Ltd.

List of Tables

Table 1. Global Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Predictive Biomarker

Table 3. Key Players of Prognostic Biomarker

Table 4. Key Players of Safety Biomarker

Table 5. Key Players of Surrogate Endpoints

Table 6. Global Biomarker Clinical Phase Outsourcing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Biomarker Clinical Phase Outsourcing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Biomarker Clinical Phase Outsourcing Services Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Biomarker Clinical Phase Outsourcing Services Market Share by Region (2020-2025)

Table 10. Global Biomarker Clinical Phase Outsourcing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Biomarker Clinical Phase Outsourcing Services Market Share by Region (2026-2031)

Table 12. Biomarker Clinical Phase Outsourcing Services Market Trends

Table 13. Biomarker Clinical Phase Outsourcing Services Market Drivers

Table 14. Biomarker Clinical Phase Outsourcing Services Market Challenges

Table 15. Biomarker Clinical Phase Outsourcing Services Market Restraints

Table 16. Global Biomarker Clinical Phase Outsourcing Services Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Biomarker Clinical Phase Outsourcing Services Market Share by Players (2020-2025)

Table 18. Global Top Biomarker Clinical Phase Outsourcing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Clinical Phase Outsourcing Services as of 2024)

Table 19. Ranking of Global Top Biomarker Clinical Phase Outsourcing Services Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Biomarker Clinical Phase Outsourcing Services Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Biomarker Clinical Phase Outsourcing Services, Headquarters and Area Served

Table 22. Global Key Players of Biomarker Clinical Phase Outsourcing Services, Product and Application

Table 23. Global Key Players of Biomarker Clinical Phase Outsourcing Services, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Biomarker Clinical Phase Outsourcing Services Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Type (2020-2025)

Table 27. Global Biomarker Clinical Phase Outsourcing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Type (2026-2031)

Table 29. Global Biomarker Clinical Phase Outsourcing Services Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Application (2020-2025)

Table 31. Global Biomarker Clinical Phase Outsourcing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Application (2026-2031)

Table 33. North America Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Country (2026-2031) & (US$ Million)

Table 48. ICON plc Company Details

Table 49. ICON plc Business Overview

Table 50. ICON plc Biomarker Clinical Phase Outsourcing Services Product

Table 51. ICON plc Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 52. ICON plc Recent Development

Table 53. Fujirebio lnc Company Details

Table 54. Fujirebio lnc Business Overview

Table 55. Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Product

Table 56. Fujirebio lnc Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 57. Fujirebio lnc Recent Development

Table 58. Charles River Laboratories International,Inc. Company Details

Table 59. Charles River Laboratories International,Inc. Business Overview

Table 60. Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Product

Table 61. Charles River Laboratories International,Inc. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 62. Charles River Laboratories International,Inc. Recent Development

Table 63. Laboratory Corporation of America Holdings Company Details

Table 64. Laboratory Corporation of America Holdings Business Overview

Table 65. Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Product

Table 66. Laboratory Corporation of America Holdings Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 67. Laboratory Corporation of America Holdings Recent Development

Table 68. Parexel lnternational Corporation Company Details

Table 69. Parexel lnternational Corporation Business Overview

Table 70. Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Product

Table 71. Parexel lnternational Corporation Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 72. Parexel lnternational Corporation Recent Development

Table 73. Proteome Sciences plc Company Details

Table 74. Proteome Sciences plc Business Overview

Table 75. Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Product

Table 76. Proteome Sciences plc Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 77. Proteome Sciences plc Recent Development

Table 78. Eurofins Scientific Company Details

Table 79. Eurofins Scientific Business Overview

Table 80. Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Product

Table 81. Eurofins Scientific Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 82. Eurofins Scientific Recent Development

Table 83. Wuxi AppTec Co., Ltd. Company Details

Table 84. Wuxi AppTec Co., Ltd. Business Overview

Table 85. Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Product

Table 86. Wuxi AppTec Co., Ltd. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 87. Wuxi AppTec Co., Ltd. Recent Development

Table 88. NorthEast BioAnalytical Laboratories LLC. Company Details

Table 89. NorthEast BioAnalytical Laboratories LLC. Business Overview

Table 90. NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Product

Table 91. NorthEast BioAnalytical Laboratories LLC. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 92. NorthEast BioAnalytical Laboratories LLC. Recent Development

Table 93. Celerion, Inc. Company Details

Table 94. Celerion, Inc. Business Overview

Table 95. Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Product

Table 96. Celerion, Inc. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 97. Celerion, Inc. Recent Development

Table 98. GenScript ProBio Co.,Ltd. Company Details

Table 99. GenScript ProBio Co.,Ltd. Business Overview

Table 100. GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Product

Table 101. GenScript ProBio Co.,Ltd. Revenue in Biomarker Clinical Phase Outsourcing Services Business (2020-2025) & (US$ Million)

Table 102. GenScript ProBio Co.,Ltd. Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Biomarker Clinical Phase Outsourcing Services Picture

Figure 2. Global Biomarker Clinical Phase Outsourcing Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biomarker Clinical Phase Outsourcing Services Market Share by Type: 2024 VS 2031

Figure 4. Predictive Biomarker Features

Figure 5. Prognostic Biomarker Features

Figure 6. Safety Biomarker Features

Figure 7. Surrogate Endpoints Features

Figure 8. Global Biomarker Clinical Phase Outsourcing Services Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Biomarker Clinical Phase Outsourcing Services Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Companies Case Studies

Figure 11. Biotechnology Companies Case Studies

Figure 12. Others Case Studies

Figure 13. Biomarker Clinical Phase Outsourcing Services Report Years Considered

Figure 14. Global Biomarker Clinical Phase Outsourcing Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Biomarker Clinical Phase Outsourcing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Biomarker Clinical Phase Outsourcing Services Market Share by Region: 2024 VS 2031

Figure 17. Global Biomarker Clinical Phase Outsourcing Services Market Share by Players in 2024

Figure 18. Global Top Biomarker Clinical Phase Outsourcing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Clinical Phase Outsourcing Services as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Biomarker Clinical Phase Outsourcing Services Revenue in 2024

Figure 20. North America Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Biomarker Clinical Phase Outsourcing Services Market Share by Country (2020-2031)

Figure 22. United States Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Biomarker Clinical Phase Outsourcing Services Market Share by Country (2020-2031)

Figure 26. Germany Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Share by Region (2020-2031)

Figure 34. China Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Biomarker Clinical Phase Outsourcing Services Market Share by Country (2020-2031)

Figure 42. Mexico Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Share by Country (2020-2031)

Figure 46. Turkey Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Biomarker Clinical Phase Outsourcing Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. ICON plc Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 50. Fujirebio lnc Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 51. Charles River Laboratories International,Inc. Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 52. Laboratory Corporation of America Holdings Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 53. Parexel lnternational Corporation Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 54. Proteome Sciences plc Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 55. Eurofins Scientific Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 56. Wuxi AppTec Co., Ltd. Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 57. NorthEast BioAnalytical Laboratories LLC. Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 58. Celerion, Inc. Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 59. GenScript ProBio Co.,Ltd. Revenue Growth Rate in Biomarker Clinical Phase Outsourcing Services Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions